Literature DB >> 19788357

Salicylates and pandemic influenza mortality, 1918-1919 pharmacology, pathology, and historic evidence.

Karen M Starko1.   

Abstract

The high case-fatality rate--especially among young adults--during the 1918-1919 influenza pandemic is incompletely understood. Although late deaths showed bacterial pneumonia, early deaths exhibited extremely "wet," sometimes hemorrhagic lungs. The hypothesis presented herein is that aspirin contributed to the incidence and severity of viral pathology, bacterial infection, and death, because physicians of the day were unaware that the regimens (8.0-31.2 g per day) produce levels associated with hyperventilation and pulmonary edema in 33% and 3% of recipients, respectively. Recently, pulmonary edema was found at autopsy in 46% of 26 salicylate-intoxicated adults. Experimentally, salicylates increase lung fluid and protein levels and impair mucociliary clearance. In 1918, the US Surgeon General, the US Navy, and the Journal of the American Medical Association recommended use of aspirin just before the October death spike. If these recommendations were followed, and if pulmonary edema occurred in 3% of persons, a significant proportion of the deaths may be attributable to aspirin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19788357     DOI: 10.1086/606060

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

Review 2.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

3.  Population-level effects of suppressing fever.

Authors:  David J D Earn; Paul W Andrews; Benjamin M Bolker
Journal:  Proc Biol Sci       Date:  2014-01-22       Impact factor: 5.349

Review 4.  Multiple roles of the coagulation protease cascade during virus infection.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

Review 5.  Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros.

Authors:  Kenneth B Ain
Journal:  Endocrine       Date:  2015-06-25       Impact factor: 3.633

6.  Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate.

Authors:  Nadine Wiesener; Christin Zimmer; Nadine Jarasch-Althof; Peter Wutzler; Andreas Henke
Journal:  Med Microbiol Immunol       Date:  2010-12-21       Impact factor: 3.402

7.  Challenges in the diagnosis of 2009 H1N1 in a lung transplant patient and the long-term implications for prevention and treatment: a case report.

Authors:  C S Davis; C R Deburghgraeve; S Yong; J P Parada; A G Palladino-Davis; E Lowery; J Gagermeier; P M Fisichella
Journal:  Transplant Proc       Date:  2010-12       Impact factor: 1.066

8.  Understanding the Influenza A H1N1 2009 Pandemic.

Authors:  Zakariya Al-Muharrmi
Journal:  Sultan Qaboos Univ Med J       Date:  2010-07-19

9.  An alternative to airborne droplet transmission route of SARS-CoV-2, the feco-oral route, as a factor shaping COVID-19 pandemic.

Authors:  Ryszard Targoński; Aleksandra Gąsecka; Adrian Prowancki; Radosław Targoński
Journal:  Med Hypotheses       Date:  2022-07-01       Impact factor: 4.411

Review 10.  The 1918 influenza pandemic: lessons for 2009 and the future.

Authors:  David M Morens; Jeffery K Taubenberger; Hillery A Harvey; Matthew J Memoli
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.